CD274 and neoplasm: Thus, tumors belonging to the “inflammatory” group may be susceptible to PD-L1 or programmed cell death 1 (PD-1) inhibitors, which would shift the balance of the inflammatory milieu towards anti-tumor cytotoxic immune responses.